Technology

Peijia Medical Announces 2024 Interim Results

HONG KONG,Aug. 26,2024-- Peijia Medical (HKG:9996),a leading Chinese domestic player in the high-growth transcatheter valve therapeuticsand neurovascular interventions markets,announced financial res

08-27 Peijia Medical

Newborn Town Selected for Fortune Magazine's China Top 50 Techs List

HONG KONG,Aug. 26,2024-- In Fortune magazine\'s China Top 50 Techs list released on 21st August,Newborn Town was charted due to its remarkable achievements in global business expansion and technologic

08-27 Newborn Town

New IBM Processor Innovations To Accelerate AI on Next-Generation IBM Z Mainframe Systems

New IBM Telum II Processor and IBM Spyre Accelerator unlock capabilities for enterprise-scale AI,including large language models and generative AI

08-27 IBM

ASLAN ENERGY CAPITAL AND PT CALYPTE SUGI POWER SIGN MEMORANDUM OF UNDERSTANDING FOR DEVELOPMENT OF POWER HUB IN INDONESIA

SINGAPORE,Aug. 26,2024-- Aslan Energy Capital,SingaporeandPT Calypte Sugi Power,Indonesiahave executed a signed a Memorandum of Understanding (MoU),to cooperate on the development of a power generati

08-27 Aslan Energy Capital

Govee Launches Permanent Outdoor Lights 2 for a Festive Holiday Season

Brighten Every Season: Second-Generation Permanent Lights for Year-Round Festivity HONG KONG,Aug. 26,2024-- Govee,a leader in the smart home lighting sector,today launched the Permanent Outdoor Lights

08-27 Govee Moments Limited

SUS ENVIRONMENT Unveils New Opportunities with Opening Ceremony of Representative Office in Thailand

BANGKOK,Aug. 23,2024-- On August 22,2024,the opening ceremony of theSUS ENVIRONMENT Thailand Representative Office was held in Bangkok,Thailand. This marks the establishment of SUS ENVIRONMENT\'s fou

08-27 Shanghai SUS ENVIRONMENT Co.,Ltd.

ArkBio Presented at the 8th Annual IPF Summit and Announced Completion of Patient Enrollment for Phase 2 Clinical Trial of AK3280, a Next-Generation Drug for IPF Treatment

BEIJING,Aug. 27,2024--Shanghai Ark Biopharmaceutical Co.,Ltd. ("ArkBio"),a privately held,clinical-stage biopharmaceutical company today announced that Dr. Jim Wu,Chief Executive Officer of

08-27 Shanghai Ark Biopharmaceutical Co., Ltd.

Hargreaves Lansdown agrees £5.4bn takeover by private equity consortium

The online investment business has agreed to be acquired by CVC Capital Partners, Nordic Capital and Platinum Ivy, a subsidiary of sovereign wealth fund the Abu Dhabi Investment Authority.

08-09 https://www.thisismoney.co.uk/money/markets/article-13726641/Hargreaves-Lansdown-agrees-5-4bn-takeover-private-equity-consortium.html

Julian Assange released from prison after reaching plea deal with US

WikiLeaks founder boarded a flight to leave the UK on Monday

06-25

The worst airlines for delays revealed

Air traffic control disruption, system outages and poor weather blamed for flight delays

06-18